Vistagen Therapeutics (VTGN) Receivables - Net (2016 - 2021)
Vistagen Therapeutics (VTGN) has disclosed Receivables - Net for 4 consecutive years, with $40600.0 as the latest value for Q1 2021.
- Quarterly Receivables - Net changed N/A to $40600.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $40600.0 through Mar 2021, changed N/A year-over-year, with the annual reading at $40600.0 for FY2021, N/A changed from the prior year.
- Receivables - Net hit $40600.0 in Q1 2021 for Vistagen Therapeutics, down from $1.2 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $40600.0 in Q1 2021 to a low of $40600.0 in Q1 2021.